Ticker League

EBITDA Margin for IDEXX Laboratories (IDXX)

As of · Reported

Metric

TTM

34.2%

YoY change

+1.40pp

Trough year (1997)

3.8%

Peak year (2025)

34.1%

EBITDA Margin history chart for IDEXX Laboratories (IDXX) from 1991 to 2025

Latest: 34.1%

EBITDA Margin change chart for IDEXX Laboratories (IDXX) from 1991 to 2025

Latest: +1.40pp

EBITDA Margin history table for IDEXX Laboratories (IDXX) from 1991 to 2025

  • 202534.1%+1.40pp
  • 202432.7%-0.53pp
  • 202333.3%+3.13pp
  • 202230.1%-2.21pp
  • 202132.3%+3.01pp
  • 202029.3%+2.58pp
  • 201926.7%+0.73pp
  • 201826.0%+0.54pp
  • 201725.5%+1.15pp
  • 201624.3%+1.20pp
  • 201523.1%+1.59pp
  • 201421.5%-1.88pp
  • 201323.4%-1.04pp
  • 201224.4%+1.08pp
  • 201123.4%+0.66pp
  • 201022.7%+0.77pp
  • 200921.9%+0.09pp
  • 200821.8%+2.62pp
  • 200719.2%-2.13pp
  • 200621.3%-0.55pp
  • 200521.9%-1.13pp
  • 200423.0%+6.14pp
  • 200316.9%+0.94pp
  • 200215.9%-4.46pp
  • 200120.4%+0.61pp
  • 200019.8%+1.83pp
  • 199918.0%+3.87pp
  • 199814.1%+10.30pp
  • 19973.8%-17.64pp
  • 199621.4%+0.98pp
  • 199520.5%-1.13pp
  • 199421.6%+2.59pp
  • 199319.0%+4.11pp
  • 199214.9%+3.10pp
  • 199111.8%—

EBITDA Margin values are taken from IDEXX Laboratories's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at IDEXX Laboratories (IDXX)

According to IDEXX Laboratories's latest reported financial statements, the company's latest reported EBITDA margin is 34.2%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

2025's annual EBITDA margin for IDEXX Laboratories (IDXX) came in at 34.13% – expanded 1.4 percentage points year-over-year.

The record annual EBITDA margin stands at 34.13%, reached in 2025; the historical low of 3.80% was recorded in 1997.

IDEXX Laboratories EBITDA Margin by Year

IDEXX Laboratories EBITDA Margin 2025: 34.1%

IDEXX Laboratories EBITDA margin in 2025 was 34.13%, expanded 1.4 percentage points from 2024. This figure represents the highest annual value in the available history.

IDEXX Laboratories EBITDA Margin 2024: 32.7%

2024's EBITDA margin for IDEXX Laboratories came in at 32.73%, contracted 0.5 percentage points from 2023.

IDEXX Laboratories EBITDA Margin 2023: 33.3%

IDEXX Laboratories posted EBITDA margin of 33.26% in 2023, expanded 3.1 percentage points from 2022.

IDEXX Laboratories EBITDA Margin 2022: 30.1%

In 2022, IDEXX Laboratories reported EBITDA margin of 30.13%, contracted 2.2 percentage points from 2021.

IDEXX Laboratories EBITDA Margin 2021: 32.3%

IDEXX Laboratories EBITDA margin in 2021 was 32.34%.

See more financial history for IDEXX Laboratories (IDXX).

Sector peers by EBITDA Margin

Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest EBITDA margin

Frequently asked questions

IDEXX Laboratories (IDXX) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Capital Return

No dividends paid by this company.